Edition:
United States

Medigen Biotechnology Corp (3176.TWO)

3176.TWO on Gre Tai Securities Market of Chinese Taipei

70.50TWD
26 Sep 2016
Change (% chg)

NT$-0.70 (-0.98%)
Prev Close
NT$71.20
Open
NT$71.90
Day's High
NT$71.90
Day's Low
NT$70.50
Volume
233
Avg. Vol
927,201
52-wk High
NT$103.00
52-wk Low
NT$50.60

Summary

Name Age Since Current Position

Shizhong Zhang

2007 Chairman of the Board

Yuren Zheng

2010 General Manager, Director

Chaoquan Ou

2011 Deputy General Manager-Finance and Accounting Management

Guanlang Lai

2005 Deputy General Manager-New Drug Development

Ziliang Huang

2001 Director

Ziling Zhang

2000 Director

Mingli Zhuang

2001 Director

Dingxin Chen

2007 Independent Director

Shengsheng Wu

2012 Independent Director

Biographies

Name Description

Shizhong Zhang

Zhang Shizhong has been Chairman of the Board in Medigen Biotechnology Corporation since June 9, 2003. Zhang was General Manager in the Company. Zhang holds a Ph.D. in Laser Medicine from University of London, the United Kingdom and a Bachelor's degree in Medicine from National Taiwan University. Zhang also serves as Director in TBG Inc. and another company.

Yuren Zheng

Zheng Yuren has been General Manager since October 12, 2007 and Director since June 24, 2010 in Medigen Biotechnology Corporation. Zheng holds a Master's degree in Business Administration from National Sun Yat-sen University, Taiwan. Zheng is also General Manager and Director in TBG Inc. and a biotechnology company. Zheng was Chief Advisor in the Company, General Manager in a United Kingdom-based company and Chief Advisor as well as Deputy General Manager in ACER INCORPORATED.

Chaoquan Ou

Ou Chaoquan is Deputy General Manager-Finance and Accounting Management in Medigen Biotechnology Corporation. Ou holds a Master of Business Administration (MBA) from National Chengchi University, Taiwan. Ou is also Chief Financial Officer in TBG Inc. Ou was Section Head-Finance and Accounting Management in the Company, Chief Financial Officer in a technology company and Manager of Finance and Accounting in CHILISIN ELECTRONICS CORP.

Guanlang Lai

Lai Guanlang has been Deputy General Manager-New Drug Development of Medigen Biotechnology Corporation since January 17, 2005. Lai holds a Ph.D. from National Defense Medical Center.

Ziliang Huang

Huang Ziliang has been Director in Medigen Biotechnology Corporation since August 13, 2001. Huang also Director in four other companies including CCH Investment Corp, Chairman of the Board in six companies, as well as Chairman of the Board and General Manager in another company. Huang holds a Bachelor's degree in Tourism from Chinese Culture University, Taiwan.

Ziling Zhang

Zhang Ziling has been Director in Medigen Biotechnology Corporation since August 23, 2000. Zhang also serves as Chairman of the Board in four companies, including Everspring Industry Co., Ltd., Director in five other companies including Phase Electronics (UK)Limited, and Chairman of the Board as well as General Manager in Everspring industry(s)PTE Ltd., Everspring Tech USA, Inc. and Bahamas Everspring industry Co.,Ltd.

Mingli Zhuang

Zhuang Mingli has been Director in Medigen Biotechnology Corporation since August 13, 2001. Zhuang also serves as Deputy General Manager in a Taiwan-based construction company.

Dingxin Chen

Chen Dingxin has been Independent Director in Medigen Biotechnology Corporation since October 12, 2007. Chen is a Professor of Medical School in National Taiwan University. Chen holds a Bachelor's degree from National Taiwan University.

Shengsheng Wu

Wu Shengsheng has been Independent Director in Medigen Biotechnology Corporation since June 28, 2012. Wu is also Deputy General Manager in Grand Cathay Securities Corp and another development company. Wu holds a Bachelor's degree from National Taiwan University and a Master's degree from National Sun Yat-sen University, Taiwan.

Basic Compensation